NUS Links:
Summary
The combination of chemotherapy (or targeted therapy) with immunotherapy is emerging rapidly as a promising strategy in the first line treatment against several tumor types. This study led by Dr Raghav Sundar provides the basis to further optimise treatment options for first-line metastatic GEAC patients using combination of Immunotherapy and chemotherapy.
Link to article: https://bit.ly/35WzvHy
Macrophages are “big eaters” in our body; they are immune cells that engulf and kill invading organisms and cancer cells. …
When a cell divides to make new cells, it needs to copy its DNA so that each new cell has …
Glioblastoma is the most common and lethal form of adult brain cancer. The presence of cancer stem cells (so-called glioma …